Express Pharma

IDT Biologika sets up new multipurpose biologics and vaccines facility

0 142

IDT Biologika has completed and certified the construction of a large-scale production facility dedicated to filling and lyophilisation of biologics and vaccine products. The fully integrated facility in Dessau, Germany, utilises a sterile liquid filling line engineered to handle up to 24,000 vials per hour. Certified to biosafety levels (BSL) 1 and 2 for live vaccines, the facility has been designed and commissioned to be used for a range of advanced biomedical technologies required in medium to large clinical stage and commercial stage volumes.

“Expanding our capabilities within a further multipurpose facility, IDT Biologika now offers one of the most dynamic facilities designed for biomedical products manufacture,” said Dr Ralf Pfirmann, Chief Executive Officer, IDT Biologika.

“Completion of this project, announced upon start of construction three years ago, allows us to accommodate production of an ever more diverse range of biomedical technologies with the precision and efficiency that comes with a highly integrated and automated facility,” he added.

Included among the company’s specialised manufacturing capabilities are drug substance and drug product capabilities for live recombinant and non-recombinant vaccines and, in separate units, fill-and-finish capabilities for other biologics and small molecule drugs including cytotoxics. All biomedical products produced in the new multipurpose facility may be manufactured in the form of liquid or freeze-dried (lyophilised) presentations.

IDT Biologika’s vaccine development team are experts in live viral vectors increasingly utilised in the development of novel vaccines. The new facility further supports these development capabilities. A fully automated loading and unloading freeze-dryer system now in place for live recombinant and non-recombinant products gives the company a leading manufacturing role in its area of expertise. A freezer-dryer shelf capacity of 40 sq mt, equal to a maximum 178,000 vials per batch, compliments its production system.

EP News BureauMumbai

- Advertisement -

Leave A Reply

Your email address will not be published.